Literature DB >> 11822868

Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence.

Marta Barradas1, Efstathios S Gonos, Zoë Zebedee, Evangelos Kolettas, Charikleia Petropoulou, M Dolores Delgado, Javier León, Eiji Hara, Manuel Serrano.   

Abstract

Normal cells display protective responses against oncogenes. Notably, oncogenic Ras triggers an irreversible proliferation arrest that is reminiscent of replicative senescence and that is considered a relevant tumor-suppressor mechanism. Here, we have used microarrayed filters to identify genes specifically upregulated in Ras-senescent human fibroblasts. Among the initial set of genes selected from the microarrays, we found the cell-cycle inhibitor p21(Cip1/Waf1), thus validating the potency of the screening to identify markers and mediators of Ras-senescence. A group of six genes, formed by those more highly upregulated during Ras-senescence, was analyzed in further detail to evaluate their specificity. In particular, we examined their expression in cells overexpressing Ras but rendered resistant to Ras-senescence by the viral oncoprotein E1a; also, we have studied their expression during replicative senescence, organismal aging, H(2)O(2)-induced senescence, and DNA damage. In this manner, we have identified a novel gene, RIS1 (for Ras-induced senescence 1), which is not upregulated in association to any of the above-mentioned processes, but exclusively during Ras-senescence. Furthermore, RIS1 is also upregulated by the transcriptional factor Ets2, which is a known mediator of Ras-induced senescence. Interestingly, RIS1 is located at chromosomal position 3p21.3 and, more specifically, it is included in a short segment of just 1 Mb previously defined by other investigators for its tumor-suppressor activity. In summary, we report the identification of a novel gene, RIS1, as a highly specific marker of Ras-induced senescence and a candidate tumor-suppressor gene. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11822868     DOI: 10.1006/excr.2001.5434

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  A new start in Madrid. Symposium on basic and translational cancer research.

Authors:  Julio E Celis
Journal:  EMBO Rep       Date:  2002-08       Impact factor: 8.807

2.  Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis.

Authors:  Lan Mo; Xiaoyong Zheng; Hong-Ying Huang; Ellen Shapiro; Herbert Lepor; Carlos Cordon-Cardo; Tung-Tien Sun; Xue-Ru Wu
Journal:  J Clin Invest       Date:  2007-01-25       Impact factor: 14.808

3.  FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence.

Authors:  Pavel Krejci; Jirina Prochazkova; Jiri Smutny; Katarina Chlebova; Patricia Lin; Anie Aklian; Vitezslav Bryja; Alois Kozubik; William R Wilcox
Journal:  Bone       Date:  2010-03-31       Impact factor: 4.398

4.  TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.

Authors:  Han-Ning Li; Ya-Ying Du; Tao Xu; Rui Zhang; Ge Wang; Zheng-Tao Lv; Xing-Rui Li
Journal:  Curr Med Sci       Date:  2021-01-11

5.  Expression analysis of novel striatal-enriched genes in Huntington disease.

Authors:  Gelareh Mazarei; Scott J Neal; Kristina Becanovic; Ruth Luthi-Carter; Elizabeth M Simpson; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

6.  Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells.

Authors:  Maria Cekanova; Joshua S Yuan; Xiuoon Li; Kyubo Kim; Seung Joon Baek
Journal:  Int J Oncol       Date:  2008-04       Impact factor: 5.650

7.  Tumor suppressor in lung cancer 1 (TSLC1) alters tumorigenic growth properties and gene expression.

Authors:  Thomas E Sussan; Mathew T Pletcher; Yoshinori Murakami; Roger H Reeves
Journal:  Mol Cancer       Date:  2005-08-05       Impact factor: 27.401

8.  Rasl11b knock down in zebrafish suppresses one-eyed-pinhead mutant phenotype.

Authors:  Guillaume Pézeron; Guillaume Lambert; Thomas Dickmeis; Uwe Strähle; Frédéric M Rosa; Philippe Mourrain
Journal:  PLoS One       Date:  2008-01-16       Impact factor: 3.240

9.  Overexpression of TMEM158 contributes to ovarian carcinogenesis.

Authors:  Zhongping Cheng; Jing Guo; Li Chen; Ning Luo; Weihong Yang; Xiaoyan Qu
Journal:  J Exp Clin Cancer Res       Date:  2015-08-04

10.  Transcriptional regulation induced by cAMP elevation in mouse Schwann cells.

Authors:  Daniela Schmid; Thomas Zeis; Nicole Schaeren-Wiemers
Journal:  ASN Neuro       Date:  2014-04-30       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.